Purpura: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 13: Line 13:
   MeshID        = D011693 |
   MeshID        = D011693 |
}}
}}
{{SI}}
{{Purpura}}
{{CMG}}
{{CMG}}


{{Editor help}}


==Overview==
==Overview==

Revision as of 16:45, 21 September 2012

For patient information click here

Purpura
ICD-10 D69
ICD-9 287
DiseasesDB 25619
MedlinePlus 003232
MeSH D011693

Purpura Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Purpura from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Purpura On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Purpura

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Purpura

CDC on Purpura

Purpura in the news

Blogs on Purpura

Directions to Hospitals Treating Purpura

Risk calculators and risk factors for Purpura

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Purpura (from the Latin, purpura, meaning "purple") is the appearance of red or purple discolorations on the skin, caused by bleeding underneath the skin. Small spots are called petechiae, while large spots are called ecchymoses.

This is common with typhus and can be present with meningitis caused by meningococcal meningitis or septicaemia.

Classification

Purpura is a common and unspecific symptom, however the underlying mechanism commonly involves one of the following:

There are also cases of psychogenic purpura described in the medical literature,[1] some claimed to be due to "autoerythrocyte sensitization". Other studies[2] suggest, that local (cutaneous) activity of tPA can be increased in psychogenic purpura, leading to substantial amounts of localized plasmin activity, rapid degradation of fibrin clots, and resultant bleeding.

Differential Diagnosis of Causes of Purpura in alphabetical order

In alphabetical order. [3] [4]

Diagnosis

History and Symptoms

  • present illness
  • medicinal history
  • system review
  • CNS symptoms

Physical examination

Laboratory Findings

  • Labs include

Treatment

Acute Pharmacotherapies

  • Infections
  • RMSF - doxycycline
  • Meningococcemia - ceftriaxone

Chronic Pharmacotherapies

  • Autoimmune disease

Primary Prevention

  • Discontinue contributory medication
  • Sun protection
  • Avoid trauma

References

  1. Anderson JE, DeGoff W, McNamara M (1999). "Autoerythrocyte sensitization (psychogenic purpura): a case report and review of the literature". Pediatric emergency care. 15 (1): 47–8. PMID 10069314.
  2. Lotti T, Benci M, Sarti MG, Teofoli P, Senesi C, Bonan P; et al. (1993). "Psychogenic purpura with abnormallt cutaney increased tPA dependeny". 32 (7): 521–3. PMID 8340191. Unknown parameter |journous fibrinolytic activital= ignored (help)
  3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:77 ISBN 1591032016
  4. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:68 ISBN 140510368X

Template:Hematology Template:SIB de:Purpura


Template:WikiDoc Sources